Effects of Time-controlled Adaptive Ventilation (TCAV) and Volume Control Ventilation (VCV) on the Distribution of Aerated Lung Parenchyma in Patients With Acute Respiratory Distress Syndrome (ARDS): a Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Acute respiratory distress syndrome (ARDS) is a severe form of acute respiratory failure with mortality rates reaching as high as 35%. Management of ARDS is based on the treatment (if possible) of the underlying cause of ARDS and on invasive mechanical ventilation with positive expiratory pressure (PEEP). Another strategy of invasive ventilation, Time-Controlled Adaptative Ventilation (TCAV), is the application of specific settings to the airway pressure release ventilation (APRV) mode. TCAV is based on a prolonged time at plateau pressure, creating a phase of continuous positive pressure, associated with brief release phases allowing the elimination of carbon dioxide. In prospective and retrospective clinical reviews, as well as in experimental animal studies, TCAV has demonstrated improvements in oxygenation and lung function, with the ability to prevent ARDS. The thoracic computed tomography (CT) scan evaluates lung recruitment (re-aeration by positive pressure of non-ventilated lung territories) and the adverse effects of positive pressure on the parenchyma (hyperinflation). The objective of this study is to evaluate, with CT scans performed to assess lungs of patients with ARDS, the effects of TCAV compared to a standard volumetric controlled ventilation, by measuring alveolar recruitment and over-distension.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ARDS according to the Berlin definition

• invasive ventilation for no longer than 72 hours

• patient requiring a diagnostic thoracic CT scan

• consent of a family member or the person of trust

• social security affiliation

Locations
Other Locations
France
CHRU
RECRUITING
Nancy
Contact Information
Primary
Benjamin Pequignot, MD
b.pequignot@chru-nancy.fr
+33383153851
Backup
Matthieu Koszutski, MD
m.koszutski@chru-nancy.fr
+3383153017
Time Frame
Start Date: 2023-10-25
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 33
Treatments
Experimental: Time-Controlled Adaptative Ventilation (TCAV)
APRV mode set with:~* a Phigh at Plateau Pressure of the VCV mode~* a Tlow set to terminate the expiration at 75% of the maximal expiratory flow~* a Plow set at 0 cmH2O.~* a Thigh set to achieve adequate decarboxylation.
Active_comparator: Volume Control Ventilation (VCV)
Ventilation with the VCV mode set with:~* a tidal volume (VT) at or below 6 ml/kg of predicted body weight~* a positive end-expiratory pressure (PEEP) set at least at 5 cmH2O~* a driving pressure lower than 15 cmH2O.
Sponsors
Leads: Central Hospital, Nancy, France

This content was sourced from clinicaltrials.gov